Cookies help us improve your ABPI online experience. If you accept their use, continue using our site. or, find out more about cookies.
Ukraine - UK Pharmaceutical Industry Response
We stand in solidarity with the people of Ukraine and condemn the invasion of their country. As an industry dedicated to saving lives, we stand for peace.
ABPI 2021 Code of Practice
The ABPI Code of Practice sets out the requirements the industry must comply with and supports companies’ commitment to self-regulation and to operate in a professional, ethical and transparent manner.
We represent our members, using their insight and experience to tell the story of how they change the lives of millions of people every day.
Online Workshop on SMC: How to prepare and submit to SMC | 13-14 June 2022
Making high quality, evidence-based submissions to SMC can mean the difference between successful or very limited access to NHS Scotland for medicines.
MMIP | 21 June 2022
The Medicines Manufacturing Industry Partnership (MMIP)'s annual conference will take place face to face this year at Redworth Hall Hotel, County Durham.
SAVE THE DATE! ABPI 2022 Annual Conference 30 June | Delivering the Life Sciences Vision: 1 Year on
The UK’s Life Sciences Vision sets out an exciting blueprint for the industry in the UK. One year on from the publication, the ABPI is bringing together leaders from across Government, NHS, industry and patient organisations to take stock on what we have already achieved together and our direction for the years ahead.
Clinical trials are important for patients, they are beneficial to the NHS and they are good for the UK economy.
Clinical research in the UK: an opportunity for growth
Clinical trials are an essential part of the research and development (R&D) of new medicines and vaccines, bringing benefits to patients, the NHS and the economy.
Clinical trial transparency
Clinical trials are the cornerstone of the research and development process and it is through trials that pharmaceutical companies are able to demonstrate the safety and efficacy of new medicines.